Gregory Russotti - 26 Jul 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
26 Jul 2024
Net transactions value
-$1,465
Form type
4
Filing time
31 Jul 2024, 09:08:48 UTC
Previous filing
25 Jul 2024
Next filing
12 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale $1,465 -586 -0.21% $2.50 274,933 26 Jul 2024 Direct F1
holding IPSC Common Stock 92,773 26 Jul 2024 By Gregory Russotti 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2024.

Remarks:

Title: Chief Technology and Manufacturing Officer